Physiology of Chemotherapy-induced Emesis and Antiemetic Therapy. Predictive Models for Evaluation of New Compounds

Overview

Journal Drugs

Specialty Pharmacology

Date 1997 Feb 1

PMID 9028742

Citations 16

Authors

C Veyrat-Follet

R Farinotti

J L Palmer

Affiliations

Soon will be listed here.

Abstract

The physiology of emesis has been studied for several hundred years, focusing on the different centres involved and the mechanics of expulsion. The vomiting centre receives inputs from various emetic detectors such as the gut, the vestibular labyrinths and the chemoreceptor trigger zone. Emesis is a common disabling effect in motion sickness, postoperative conditions and in radio- and chemotherapy. Our current understanding of the mechanisms has been provided mainly by the recent introduction of serotonin 5-HT3 receptor antagonists into therapeutic use. Nevertheless, despite the considerable advances made in the understanding of the different pathways involved in emesis, there are number of areas that still require experimental investigation. Different animal and human models are available to study the physiology of emesis and to evaluate the antiemetic activity of new compounds, but they need to be predictors of clinical situations.

Citing Articles

Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Zhong W, Shahbaz O, Teskey G, Beever A, Kachour N, Venketaraman V Int J Mol Sci. 2021; 22(11).

PMID: 34071460 PMC: 8198651. DOI: 10.3390/ijms22115797.

Suppression of Cisplatin-Induced Vomiting by in Pigeons: Neurochemical Evidences.

Ullah I, Subhan F, Alam J, Shahid M, Ayaz M Front Pharmacol. 2018; 9:231.

PMID: 29615907 PMC: 5865282. DOI: 10.3389/fphar.2018.00231.

Protein calorie malnutrition, nutritional intervention and personalized cancer care.

Gangadharan A, Choi S, Hassan A, Ayoub N, Durante G, Balwani S Oncotarget. 2017; 8(14):24009-24030.

PMID: 28177923 PMC: 5410360. DOI: 10.18632/oncotarget.15103.

Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.

Ullah I, Subhan F, Ayaz M, Shah R, Ali G, Ul Haq I BMC Complement Altern Med. 2015; 15:34.

PMID: 25888212 PMC: 4355376. DOI: 10.1186/s12906-015-0556-0.

The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: a prospective, randomized, double-blinded study.

Tsutsumi Y, Kakuta N, Soga T, Kume K, Hamaguchi E, Tsutsumi R Biomed Res Int. 2014; 2014:307025.

PMID: 25050340 PMC: 4094853. DOI: 10.1155/2014/307025.

References

Mitchelson F . Pharmacological agents affecting emesis. A review (Part I). Drugs. 1992; 43(3):295-315. DOI: 10.2165/00003495-199243030-00002. View

Lang I, Sarna S, Dodds W . Pharyngeal, esophageal, and proximal gastric responses associated with vomiting. Am J Physiol. 1993; 265(5 Pt 1):G963-72. DOI: 10.1152/ajpgi.1993.265.5.G963. View

Harding R, Hugenholtz H, Keaney M, Kucharczyk J . Discrete lesions of the area postrema abolish radiation-induced emesis in the dog. Neurosci Lett. 1985; 53(1):95-100. DOI: 10.1016/0304-3940(85)90103-x. View

Cubeddu L, Hoffmann I . Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics. J Clin Pharmacol. 1993; 33(8):691-7. DOI: 10.1002/j.1552-4604.1993.tb05608.x. View

Hainsworth J, Omura G, Khojasteh A, BRYSON J, Finn A . Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy. Am J Clin Oncol. 1991; 14(4):336-40. View

Leslie R, Shah Y, Thejomayen M, Murphy K, Robertson H . The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting. Can J Physiol Pharmacol. 1990; 68(2):279-88. DOI: 10.1139/y90-042. View

Carl P, Cubeddu L, Lindley C, Myers R, Rezvani A . Do humoral factors mediate cancer chemotherapy-induced emesis?. Drug Metab Rev. 1989; 21(2):319-33. DOI: 10.3109/03602538909029944. View

Aapro M . 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis. Drugs. 1991; 42(4):551-68. DOI: 10.2165/00003495-199142040-00002. View

Smith W, Callaham E, ALPHIN R . The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride. J Pharm Pharmacol. 1988; 40(2):142-3. DOI: 10.1111/j.2042-7158.1988.tb05202.x. View

10.

Carpenter D . Neural mechanisms of emesis. Can J Physiol Pharmacol. 1990; 68(2):230-6. DOI: 10.1139/y90-036. View

11.

Stewart D . Cancer therapy, vomiting, and antiemetics. Can J Physiol Pharmacol. 1990; 68(2):304-13. DOI: 10.1139/y90-045. View

12.

Sanger G . New antiemetic drugs. Can J Physiol Pharmacol. 1990; 68(2):314-24. DOI: 10.1139/y90-046. View

13.

Gardner C, Twissell D, Dale T, Gale J, Jordan C, Kilpatrick G . The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040. Br J Pharmacol. 1995; 116(8):3158-63. PMC: 1909155. DOI: 10.1111/j.1476-5381.1995.tb15118.x. View

14.

Fukui H, Yamamoto M, Sasaki S, Sato S . Possible involvement of peripheral 5-HT4 receptors in copper sulfate-induced vomiting in dogs. Eur J Pharmacol. 1994; 257(1-2):47-52. DOI: 10.1016/0014-2999(94)90692-0. View

15.

Hoyer D, Clarke D, Fozard J, Hartig P, Martin G, Mylecharane E . International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 1994; 46(2):157-203. View

16.

Jovanovic-Micic D, Samardzic R, Beleslin D . The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis. Eur J Pharmacol. 1995; 272(1):21-30. DOI: 10.1016/0014-2999(94)00622-e. View

17.

Watson J, Gonsalves S, Fossa A, McLean S, Seeger T, Obach S . The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor. Br J Pharmacol. 1995; 115(1):84-94. PMC: 1908747. DOI: 10.1111/j.1476-5381.1995.tb16324.x. View

18.

Bhandari P, Bingham S, Andrews P . The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacology. 1992; 31(8):735-42. DOI: 10.1016/0028-3908(92)90034-m. View

19.

Craig J, Powell B, White D, CAPIZZI R . Antiemetic therapy in patients treated with high-dose cytosine arabinoside. Oncology. 1987; 44(2):90-2. DOI: 10.1159/000226452. View

20.

Minton N . Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists. Br J Clin Pharmacol. 1994; 37(6):525-30. PMC: 1364809. DOI: 10.1111/j.1365-2125.1994.tb04298.x. View